Immunicon To Begin Offering Novel Breast Cancer Test To Researchers
This article was originally published in The Gray Sheet
Executive Summary
Immunicon will commence sales to the research community as early as June of its novel blood test for detection and monitoring of breast cancer, the Huntingdon Valley, Pennsylvania company says.